AMG 386 Drug-Drug Interaction Study With Paclitaxel

Clinical trial NCT01992341 · COMPLETED

Trial details

NCT number: NCT01992341
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2012-07-01
Primary completion: 2013-08-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.